SUD Level-of-Care Assessment & Placement Recommendation Note

A structured SUD level-of-care assessment note for placement decisions, utilization review, or authorization requests. Organized around a multidimensional assessment framework aligned with ASAM Criteria, with required sa…

Document Type

clinical note / Diagnostic Evaluation Note

Specialties

Addiction Medicine
Created by Augustun

Template Preview

(Omit sections where information was not obtained or not applicable, except: the Safety & Risk Assessment must always appear—document "not assessed" with reason if elements cannot be evaluated; the Multidimensional Assessment table must include all six dimensions; and the Level of Care Recommendation must always include a concrete recommendation or specify what additional information is needed with a timeline to obtain it.)

Date: [Encounter date]

Clinician: [Name and credentials]

Patient: [Name], [DOB], [MRN]

Encounter Type: [in-person / telehealth video / telehealth audio-only / chart review / combination]

Setting: [ED / inpatient consult / outpatient clinic / residential intake / correctional / outreach / other]

Assessment Type: [initial placement / step-up / step-down / continued stay review / return after disengagement / court-mandated evaluation]

Time: [Start time], [Stop time], [Total time] (Include only if required by payer or local policy.)

Referral Question & Patient Goals

[Referral source and reason for assessment]

[Patient's stated goals and treatment preferences, including factors affecting placement: location, family/work obligations, language or cultural needs, modality preference, scheduling constraints]

Clinical Synopsis

[Integrated summary of primary substances and current use pattern; main risks including withdrawal severity, overdose, suicidality, medical or psychiatric instability; relevant social determinants and barriers; prior treatment exposure and response; key drivers of the placement question] (4–8 sentences in narrative format.)

Safety & Risk Assessment

(This section is required. If any element cannot be evaluated, document "not assessed" with reason.)

Suicidal/Homicidal Ideation

  • Suicidal ideation: [none / passive / active]; Intent: [yes / no]; Plan: [yes / no]; Recent behavior: [description] (If positive, document immediate safety measures taken.)
  • Homicidal ideation/violence risk: [description] (Include access to weapons and protective actions if relevant.)

Overdose Risk

  • [Recent overdose history and context]
  • [Use alone vs. supervised use]
  • [Fentanyl exposure, unknown potency, or counterfeit pills]
  • [Polysubstance use with respiratory depressants]
  • [Loss of tolerance due to recent abstinence, incarceration, or hospitalization]
  • Naloxone: [education provided: yes / no]; [dispensed/prescribed: yes / no]

Withdrawal Status

  • Alcohol: [Time since last use]; [Typical daily amount]; [Prior complicated withdrawal: seizures / delirium tremens / none]; [CIWA-Ar score and interpretation if obtained]
  • Benzodiazepines: [Time since last use]; [Typical daily amount]; [Prior complicated withdrawal]; [Severity score if obtained]
  • Opioids: [Time since last use]; [Typical daily amount]; [Prior complicated withdrawal]; [COWS score and interpretation if obtained]
  • Withdrawal management indicated: [yes / no]; [Recommended intensity/setting]; [Brief rationale]

Acute Mental Status

  • [Intoxication severity and substances suspected]
  • [Psychosis, mania, agitation, or delirium and effect on capacity]
  • [Immediate interventions required or need for higher-acuity evaluation]

Substance Use & Treatment History

(Repeat the following for each clinically relevant substance.)

[Substance name]

  • Route/Frequency/Quantity/Duration: [Details]
  • Last use: [Date/time]
  • Tolerance/Withdrawal history: [Description]
  • High-risk practices: [Injection, equipment sharing, unsafe sources]
  • Consequences: [Medical, legal, social, occupational]
  • Overdose history: [Number, dates, naloxone use, medical care required]

Treatment History

  • Prior SUD treatment: [Levels of care with approximate dates; completion vs. early discontinuation]
  • Response and barriers: [Factors contributing to relapse or disengagement]
  • MOUD history: [Buprenorphine / methadone / naltrexone]; [Response]; [Adherence]; [Reasons for discontinuation if applicable]
  • Recovery supports: [Mutual-help programs, peer specialist, recovery housing]

Medical, Psychiatric & Social Factors

Medical

  • [Conditions affecting withdrawal risk or medical stability]
  • [Current medications relevant to placement]
  • [Contraindications to withdrawal medications or MOUD]

Psychiatric

  • [Current symptoms and diagnoses affecting safety or program fit]
  • [Current psychiatric medications and adherence]

Social/Environmental

  • [Housing status and safety]
  • [Substance use exposure in the home or social network]
  • [Legal status and court mandates]
  • [Employment, school, or caregiving responsibilities]
  • [Available supports and recovery capital]

Data Sources & Objective Findings

Sources Reviewed

  • [Patient interview, chart review, PDMP, prior records, collateral contacts]
  • Patient reliability: [good / fair / limited] (If limited, specify reason.)

Vitals/Exam

[Vital signs and focused physical/mental status exam findings] (If not obtained, briefly state reason.)

Toxicology & Labs

  • Toxicology: [Presumptive / confirmatory]; [Date]; [Results]; [Interpretive caveats]
  • Relevant labs: [LFTs, pregnancy, infectious disease screening with placement implications]

Multidimensional Assessment

(Rate each dimension using organizational standard. If a dimension could not be fully assessed, note the reason in Key Findings.)

Dimension Severity Key Findings Service Needs
1. Intoxication/Withdrawal Potential [low / moderate / high] [Key findings] [Service intensity needed]
2. Biomedical Conditions [low / moderate / high] [Key findings] [Service intensity needed]
3. Emotional/Behavioral/Cognitive [low / moderate / high] [Key findings] [Service intensity needed]
4. Relapse/Continued Use Potential [low / moderate / high] [Key findings] [Service intensity needed]
5. Recovery Environment [low / moderate / high] [Key findings] [Service intensity needed]
6. Person-Centered Considerations [low / moderate / high] [Key findings] [Service intensity needed]

[Narrative support for dimensions rated moderate or higher that drive placement recommendation] (Low-severity dimensions need only a single confirmatory sentence.)

Diagnoses

  • [SUD diagnosis] [mild / moderate / severe] [early remission / sustained remission / on maintenance therapy] (Use "provisional" with explanation if diagnosis cannot be finalized.)
  • [Additional SUD diagnoses with severity and specifiers]
  • [Co-occurring mental health diagnoses affecting placement] (Include only if relevant to LOC decision.)

Level of Care Recommendation

Recommended LOC: [ASAM level of care]

Withdrawal Management: [WM level / not indicated]

Timing: [immediate / within 24 hours / scheduled]

Rationale:

  • [Dimensional driver with supporting clinical facts]
  • [Dimensional driver with supporting clinical facts]
  • [Dimensional driver with supporting clinical facts]
  • [Why lower LOC is inadequate, citing specific facts]
  • [Why higher LOC is not required] (Include if relevant.)

Alternatives Considered:

  • [Lower LOC considered and reason rejected]
  • [Higher LOC not indicated and reason]

If Patient Declines Recommended LOC

(Include this subsection only if patient declines recommended placement.)

  • [Refusal documented and patient's stated reasons]
  • [Capacity assessment findings]
  • [Risk/benefit discussion held]
  • [Best feasible alternative plan with follow-up and return precautions]

Placement Plan & Coordination

  • Referrals: [Programs contacted, date/time, acceptance/waitlist status, next steps]
  • Barrier Mitigation: [Transportation, childcare, peer support, scheduling accommodations, language assistance]

Interim Plan

(Include if placement is delayed.)

  • [Harm reduction steps]
  • [Medication bridging]
  • [Follow-up cadence]
  • [Contingency if symptoms worsen]

Safety Plan

(Include if suicide, overdose, or other acute risk is present.)

  • [Crisis resources provided]
  • [ED return precautions]
  • [Overdose prevention instructions]
  • [Safe medication storage]

Disclosure Authorization

Consent for external disclosure: [yes / no / pending]

[Date obtained and authorized scope] (If consent not obtained, state that external disclosure is not currently authorized.)

Want to use this template?

Copy it into your workflow, or book a demo to see Augustun draft notes like this automatically.